stat view graphics computer software (Abacus Concepts)
90
Structured Review
Abacus Concepts
stat view graphics computer software
Stat View Graphics Computer Software, supplied by Abacus Concepts, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stat+view+software+program/stat+view+graphics+computer+software/pm16778365-48-26-21
Average 90 stars, based on 1 article reviews
Stat View Graphics Computer Software, supplied by Abacus Concepts, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stat+view+software+program/stat+view+graphics+computer+software/pm16778365-48-26-21
Average 90 stars, based on 1 article reviews
stat view graphics computer software - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Mizoribine treatment of young patients with severe lupus nephritis: a clinicopathologic study by the tohoku pediatric study group. Article Snippet: Background: A novel purine synthesis inhibitor, mizoribine (MZR), with a similar activity to that of mycophenolate mofetil, was developed in Japan.. We suspected that longterm oral MZR intermittent pulse therapy (MZR-P) might be more effective than the conventional daily MZR regimen due to the higher peak serum MZR levels that are achieved.. Here, we examined the clinicopathologic efficacy of MZR-P treatment in 10 young patients with diffuse proliferative lupus nephritis (DPLN), including 3 patients who received MZR-P as their primary cytotoxic therapy. Software:Article Title: Renal biopsy findings in children receiving long-term treatment with cyclosporine a given as a single daily dose. Article Snippet: .. Data were expressed as the mean ± S.D., and the statistical analysis was performed by Wilcoxon’s U-test using Article Title: Single-dose daily administration of cyclosporin A for relapsing nephrotic syndrome. Article Snippet: Cyclosporin A (CsA) has been reported to be effective as a steroid-sparing agent in frequently relapsing nephrotic syndrome (FRNS).. However, low efficacy has sometimes been observed in selected patients with steroid-dependent FRNS.. We speculated that a low peak level of CsA in the blood might be the cause, and conducted a prospective pilot study on such steroid-dependent FRNS patients to examine whether single-dose daily administration of CsA would yield a sufficient peak blood level, and therefore a satisfactory steroid-sparing effect. Article Title: Novel multidrug therapy for children with cyclosporine-resistant or -intolerant nephrotic syndrome. Article Snippet: An effective treatment for children with refractory nephrotic syndrome (NS), especially in those with cyclosporine (CsA)-resistant or CsA-intolerant NS, has yet to be established.. Recently, the efficacy of multidrug therapy consisting of tacrolimus (Tac), mycophenolate mofetil (MMF) in combination with prednisolone (PDN) in adult patients with refractory NS has been reported.. We successfully treated 14 consecutive children with refractory CsA-resistant or CsA-intolerant NS using combination therapy consisting of relatively low-dose Tac, mizoribine (MZR), which has a mechanism of action very similar to that of MMF, and PDN. |